ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
2L9,BLUEPRINT MEDICINES CORP,09627Y109,60015000.0,2278459,10.22780141892318,2016-02-16,2015-12-31,0000921895-16-003386
CCXIEUR,CHEMOCENTRYX INC,16383L106,54090000.0,6677722,9.21805846454311,2016-02-16,2015-12-31,0000921895-16-003386
N/A,CTI BIOPHARMA CORP,12648L106,53869000.0,43795613,9.180395478396614,2016-02-16,2015-12-31,0000921895-16-003386
CNCEEUR,CONCERT PHARMACEUTICALS INC,206022105,42341000.0,2232014,7.215785051714177,2016-02-16,2015-12-31,0000921895-16-003386
N/A,ONCOTHYREON INC,682324108,41735000.0,18799368,7.11251007612695,2016-02-16,2015-12-31,0000921895-16-003386
N/A,VITAE PHARMACEUTICALS INC,92847N103,37310000.0,2061325,6.358398249438038,2016-02-16,2015-12-31,0000921895-16-003386
IRWD,IRONWOOD PHARMACEUTICALS INC,46333X108,34028000.0,2935975,5.799077342049787,2016-02-16,2015-12-31,0000921895-16-003386
CYTK,CYTOKINETICS INC,23282W605,30550000.0,2920628,5.206353967309892,2016-02-16,2015-12-31,0000921895-16-003386
ARRYEUR,ARRAY BIOPHARMA INC,04269X105,28201000.0,6682711,4.80603562134554,2016-02-16,2015-12-31,0000921895-16-003386
N/A,FORWARD PHARMA A/S,34986J105,27384000.0,1441287,4.666801867129757,2016-02-16,2015-12-31,0000921895-16-003386
N/A,ONCOMED PHARMACEUTICALS INC,68234X102,22347000.0,991433,3.8083925403428522,2016-02-16,2015-12-31,0000921895-16-003386
EXEL 4.25 08/15/19,EXELIXIS INC,30161QAC8,22187000.0,18842778,3.7811252200557957,2016-02-16,2015-12-31,0000921895-16-003386
N/A,LOXO ONCOLOGY INC,548862101,20230000.0,711067,3.447611808794733,2016-02-16,2015-12-31,0000921895-16-003386
ARQLUSD,ARQULE INC,04269E107,14777000.0,6809843,2.518307449261482,2016-02-16,2015-12-31,0000921895-16-003386
N/A,QLT INC,746927102,14269000.0,5364385,2.4317337073500767,2016-02-16,2015-12-31,0000921895-16-003386
CTMX,CYTOMX THERAPEUTICS INC,23284F105,12707000.0,608848,2.1655364930476857,2016-02-16,2015-12-31,0000921895-16-003386
N/A,TOBIRA THERAPEUTICS INC,88883P101,12597000.0,1253401,2.146790210350334,2016-02-16,2015-12-31,0000921895-16-003386
FPRX,FIVE PRIME THERAPEUTICS INC,33830X104,12450000.0,300000,2.1217383598366006,2016-02-16,2015-12-31,0000921895-16-003386
N/A,NIVALIS THERAPEUTICS INC,65481J109,9249000.0,1195013,1.5762215333436722,2016-02-16,2015-12-31,0000921895-16-003386
XENE,XENON PHARMACEUTICALS INC,98420N105,9050000.0,1125572,1.5423078037366453,2016-02-16,2015-12-31,0000921895-16-003386
N/A,GTX INC DEL,40052B108,7814000.0,11163136,1.3316677545191324,2016-02-16,2015-12-31,0000921895-16-003386
N/A,SUNESIS PHARMACEUTICALS INC,867328601,4288000.0,4777381,0.73076418369312,2016-02-16,2015-12-31,0000921895-16-003386
N/A,PAIN THERAPEUTICS INC,69562K100,3242000.0,1852353,0.5525040773164867,2016-02-16,2015-12-31,0000921895-16-003386
N/A,CATALYST BIOSCIENCES INC,14888D109,3039000.0,970948,0.5179086647022835,2016-02-16,2015-12-31,0000921895-16-003386
GBIM,GLOBEIMMUNE INC,37957B100,2539000.0,657653,0.4326982888052312,2016-02-16,2015-12-31,0000921895-16-003386
ARRY 3 06/01/20,ARRAY BIOPHARMA INC,04269XAA3,2327000.0,2500000,0.3965690894248811,2016-02-16,2015-12-31,0000921895-16-003386
N/A,MAST THERAPEUTICS INC,576314108,1554000.0,3696961,0.26483384828803835,2016-02-16,2015-12-31,0000921895-16-003386
CALAEUR,CALITHERA BIOSCIENCES INC,13089P101,1286000.0,167900,0.21916108680721832,2016-02-16,2015-12-31,0000921895-16-003386
N/A,BIOTA PHARMACEUTIALS INC,090694100,681000.0,350776,0.11605653197178514,2016-02-16,2015-12-31,0000921895-16-003386
N/A,NEPHROGENEX INC,640667101,627000.0,392156,0.1068538113749035,2016-02-16,2015-12-31,0000921895-16-003386
